Topical interferon alpha-2b for treatment of noninvasive ocular surface squamous neoplasia with 360° limbal involvement.

J Ophthalmic Vis Res · 2014 · PMC4329700 · PMID 25709765

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although, not statistically significant, their results showed a trend toward increased success rates and faster resolution of the lesion in the 3 million IU/ml group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.